Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.095 USD | +10.26% | -7.90% | -38.60% |
03:25pm | Truist Securities Trims Price Target on Coherus BioSciences to $7 From $8, Maintains Buy Rating | MT |
May. 09 | Transcript : Coherus BioSciences, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.60% | 218M | |
+4.58% | 109B | |
+11.70% | 105B | |
+0.76% | 22.25B | |
-11.58% | 22.09B | |
-7.56% | 18.68B | |
-38.36% | 17.58B | |
-10.50% | 16.85B | |
+4.74% | 13.76B | |
+36.89% | 12.46B |
- Stock Market
- Equities
- CHRS Stock
- News Coherus BioSciences, Inc.
- Transcript : Coherus BioSciences, Inc., Q2 2023 Earnings Call, Aug 02, 2023